Documents
Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | CAPSULE;ORAL | 5MG | 0 | ZALEPLON | ZALEPLON |
002 | CAPSULE;ORAL | 10MG | 0 | ZALEPLON | ZALEPLON |
FDA Submissions
| ORIG | 1 | AP | 2008-11-25 | |
LABELING; Labeling | SUPPL | 2 | AP | 2019-12-06 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
CDER Filings
HIKMA PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 78147
[companyName] => HIKMA PHARMS
[docInserts] => ["",""]
[products] => [{"drugName":"ZALEPLON","activeIngredients":"ZALEPLON","strength":"5MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"ZALEPLON","activeIngredients":"ZALEPLON","strength":"10MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ZALEPLON","submission":"ZALEPLON","actionType":"5MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"ZALEPLON","submission":"ZALEPLON","actionType":"10MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)